Tokyo Tape
Sign in
← Astena Holdings

Quarterly report · Q2

8095.TEDINET S100OPJO
Period2021-12-01 → 2022-05-31
Filed2022-07-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥24.9bn2021-12-01 → 2022-05-31Cons.Net sales
Revenue¥72.3bn2020-12-01 → 2021-11-30Cons.Net sales (5-year summary)
Revenue¥36.2bn2020-12-01 → 2021-05-31Cons.Net sales
Operating income¥720m2021-12-01 → 2022-05-31Cons.Operating income
Operating income¥1.5bn2020-12-01 → 2021-05-31Cons.Operating income
Ordinary income¥835m2021-12-01 → 2022-05-31Cons.Ordinary income
Ordinary income¥2.4bn2020-12-01 → 2021-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.6bn2020-12-01 → 2021-05-31Cons.Ordinary income
Profit before tax¥1.5bn2021-12-01 → 2022-05-31Cons.Income before income taxes
Profit before tax¥1.6bn2020-12-01 → 2021-05-31Cons.Income before income taxes
Net income (owners)¥933m2021-12-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.7bn2020-12-01 → 2021-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥976m2020-12-01 → 2021-05-31Cons.Profit loss attributable to owners of parent
Net income¥928m2021-12-01 → 2022-05-31Cons.Profit loss
Net income¥976m2020-12-01 → 2021-05-31Cons.Profit loss
Total assets¥63.9bnat 2022-05-31Cons.Assets
Total assets¥63.6bnat 2021-11-30Cons.Assets
Total assets¥60.3bnat 2021-05-31Cons.Total assets (5-year summary)
Total liabilities¥36.0bnat 2022-05-31Cons.Liabilities
Total liabilities¥36.5bnat 2021-11-30Cons.Liabilities
Net assets / equity¥27.8bnat 2022-05-31Cons.Net assets
Net assets / equity¥27.0bnat 2021-11-30Cons.Net assets
Net assets / equity¥25.4bnat 2021-05-31Cons.Net assets (5-year summary)
Cash and deposits¥10.4bnat 2022-05-31Cons.Cash and deposits
Cash and deposits¥10.9bnat 2021-11-30Cons.Cash and deposits
Cash & equivalents¥10.3bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥10.8bnat 2021-11-30Cons.Cash and cash equivalents
Cash & equivalents¥10.9bnat 2021-05-31Cons.Cash and cash equivalents
Cash & equivalents¥7.4bnat 2020-11-30dCons.Cash and cash equivalents
Operating cash flow¥1.3bn2021-12-01 → 2022-05-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.3bn2020-12-01 → 2021-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.3bn2020-12-01 → 2021-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥23m2021-12-01 → 2022-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥4.4bn2020-12-01 → 2021-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.5bn2020-12-01 → 2021-05-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.9bn2021-12-01 → 2022-05-31Cons.Net cash provided by used in financing activities
Financing cash flow¥6.4bn2020-12-01 → 2021-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.6bn2020-12-01 → 2021-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥23.332021-12-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.082022-03-01 → 2022-05-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.862020-12-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.062020-12-01 → 2021-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥16.062021-03-01 → 2021-05-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥46.632020-12-01 → 2021-11-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥27.762020-12-01 → 2021-05-31Cons.Diluted earnings per share (5-year summary)
Equity ratio43.5%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio42.5%at 2021-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio42.1%at 2021-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 57
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-12-01 → 2022-05-31¥807,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-12-01 → 2022-05-31¥807,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-12-01 → 2022-05-31−¥19m
Reconciling Itemsreconcilingrevenue2021-12-01 → 2022-05-31−¥740m
Reconciling Itemsreconcilingrevenue intersegment2021-12-01 → 2022-05-31−¥740m
Reconciling Itemsreconcilingsegment profit2021-12-01 → 2022-05-31¥17m
jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segmentrevenue2021-12-01 → 2022-05-31¥7.9bn
jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segmentrevenue external2021-12-01 → 2022-05-31¥7.5bn
jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2021-12-01 → 2022-05-31¥348m
jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segmentsegment profit2021-12-01 → 2022-05-31¥474m
jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2021-12-01 → 2022-05-31¥7.3bn
jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2021-12-01 → 2022-05-31¥7.2bn
jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2021-12-01 → 2022-05-31¥105m
jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2021-12-01 → 2022-05-31−¥66m
jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segmentrevenue2021-12-01 → 2022-05-31¥4.4bn
jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segmentrevenue external2021-12-01 → 2022-05-31¥4.3bn
jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2021-12-01 → 2022-05-31¥52m
jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segmentsegment profit2021-12-01 → 2022-05-31−¥38m
jpcrp040300-q2r_E02585-000Medicalreportable segmentrevenue2021-12-01 → 2022-05-31¥6.1bn
jpcrp040300-q2r_E02585-000Medicalreportable segmentrevenue external2021-12-01 → 2022-05-31¥5.9bn
jpcrp040300-q2r_E02585-000Medicalreportable segmentrevenue intersegment2021-12-01 → 2022-05-31¥235m
jpcrp040300-q2r_E02585-000Medicalreportable segmentsegment profit2021-12-01 → 2022-05-31¥353m
—segment totalrevenue2021-12-01 → 2022-05-31¥25.7bn
—segment totalrevenue external2021-12-01 → 2022-05-31¥24.9bn
—segment totalrevenue intersegment2021-12-01 → 2022-05-31¥740m
—segment totalsegment profit2021-12-01 → 2022-05-31¥722m
Total Of Reportable Segments And Otherssegment totalrevenue2021-12-01 → 2022-05-31¥25.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-12-01 → 2022-05-31¥24.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-12-01 → 2022-05-31¥740m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-12-01 → 2022-05-31¥704m
Reconciling Itemsreconcilingrevenue2020-12-01 → 2021-05-31−¥641m
Reconciling Itemsreconcilingrevenue intersegment2020-12-01 → 2021-05-31−¥641m
Reconciling Itemsreconcilingsegment profit2020-12-01 → 2021-05-31−¥10m
jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segmentrevenue2020-12-01 → 2021-05-31¥12.1bn
jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segmentrevenue external2020-12-01 → 2021-05-31¥11.6bn
jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2020-12-01 → 2021-05-31¥500m
jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segmentsegment profit2020-12-01 → 2021-05-31¥726m
jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2020-12-01 → 2021-05-31¥14.0bn
jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2020-12-01 → 2021-05-31¥14.0bn
jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2020-12-01 → 2021-05-31¥4m
jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2020-12-01 → 2021-05-31−¥350m
jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segmentrevenue2020-12-01 → 2021-05-31¥4.1bn
jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segmentrevenue external2020-12-01 → 2021-05-31¥4.1bn
jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2020-12-01 → 2021-05-31¥36m
jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segmentsegment profit2020-12-01 → 2021-05-31¥206m
jpcrp040300-q2r_E02585-000Medicalreportable segmentrevenue2020-12-01 → 2021-05-31¥6.6bn
jpcrp040300-q2r_E02585-000Medicalreportable segmentrevenue external2020-12-01 → 2021-05-31¥6.5bn
jpcrp040300-q2r_E02585-000Medicalreportable segmentrevenue intersegment2020-12-01 → 2021-05-31¥102m
jpcrp040300-q2r_E02585-000Medicalreportable segmentsegment profit2020-12-01 → 2021-05-31¥923m
—segment totalrevenue2020-12-01 → 2021-05-31¥36.9bn
—segment totalrevenue external2020-12-01 → 2021-05-31¥36.2bn
—segment totalrevenue intersegment2020-12-01 → 2021-05-31¥641m
—segment totalsegment profit2020-12-01 → 2021-05-31¥1.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2020-12-01 → 2021-05-31¥36.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2020-12-01 → 2021-05-31¥36.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2020-12-01 → 2021-05-31¥641m
Total Of Reportable Segments And Otherssegment totalsegment profit2020-12-01 → 2021-05-31¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 638
ItemContextValueUnit
Capital stockPrior1YearInstant4528304000JPY
Capital stockCurrentQuarterInstant4557400000JPY
Capital surplusPrior1YearInstant6516607000JPY
Capital surplusCurrentQuarterInstant6538828000JPY
Retained earningsPrior1YearInstant15027322000JPY
Retained earningsCurrentQuarterInstant15752072000JPY
Treasury stockPrior1YearInstant-254106000JPY
Treasury stockCurrentQuarterInstant-234779000JPY
Shareholders equityPrior1YearInstant25818127000JPY
Shareholders equityCurrentQuarterInstant26613522000JPY
Valuation difference on available for sale securitiesPrior1YearInstant985867000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant906240000JPY
Deferred gains or losses on hedgesPrior1YearInstant-763000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant763000JPY
Foreign currency translation adjustmentPrior1YearInstant103839000JPY
Foreign currency translation adjustmentCurrentQuarterInstant180788000JPY
Remeasurements of defined benefit plansPrior1YearInstant92615000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant86579000JPY
Valuation and translation adjustmentsPrior1YearInstant1181558000JPY
Valuation and translation adjustmentsCurrentQuarterInstant1174373000JPY
Non controlling interestsPrior1YearInstant6586000JPY
Non controlling interestsCurrentQuarterInstant42001000JPY
Net assetsPrior1YearInstant27006272000JPY
Net assetsCurrentQuarterInstant27829897000JPY
Liabilities and net assetsPrior1YearInstant63553650000JPY
Liabilities and net assetsCurrentQuarterInstant63871453000JPY
Net salesPrior1YTDDuration36249985000JPY
Net salesCurrentYTDDuration24934991000JPY
Cost of salesPrior1YTDDuration27676571000JPY
Cost of salesCurrentYTDDuration16782199000JPY
Gross profitPrior1YTDDuration8573413000JPY
Gross profitCurrentYTDDuration8152791000JPY
Selling general and administrative expensesPrior1YTDDuration7078582000JPY
Selling general and administrative expensesCurrentYTDDuration7432742000JPY
Operating incomePrior1YTDDuration1494831000JPY
Operating incomeCurrentYTDDuration720049000JPY
Interest income noiPrior1YTDDuration1241000JPY
Interest income noiCurrentYTDDuration1215000JPY
Dividends income noiPrior1YTDDuration25650000JPY
Dividends income noiCurrentYTDDuration27451000JPY
Rent income noiPrior1YTDDuration24006000JPY
Rent income noiCurrentYTDDuration8896000JPY
Foreign exchange gains noiPrior1YTDDuration3012000JPY
Foreign exchange gains noiCurrentYTDDuration49518000JPY
Other noiPrior1YTDDuration88609000JPY
Other noiCurrentYTDDuration90448000JPY
Non operating incomePrior1YTDDuration142521000JPY
Non operating incomeCurrentYTDDuration177530000JPY
Interest expenses noePrior1YTDDuration28098000JPY
Interest expenses noeCurrentYTDDuration26931000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2021-11-30pass rounding
balance sheet identityconsolidated 2022-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-11-30pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2020-12-01/2021-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-12-01/2022-05-31pass
statement vs summary · operating cash flowconsolidated 2020-12-01/2021-05-31pass
statement vs summary · operating cash flowconsolidated 2021-12-01/2022-05-31pass
statement vs summary · revenueconsolidated 2020-12-01/2021-05-31pass
statement vs summary · revenueconsolidated 2021-12-01/2022-05-31pass
statement vs summary · total assetsconsolidated 2021-11-30pass
statement vs summary · total assetsconsolidated 2022-05-31pass